KwdFr.i
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration sur la COVID en France - Exploration (Accueil)

Index « KwdFr.i » - entrée « Pneumopathie virale (traitement médicamenteux) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Pneumopathie virale (thérapie) < Pneumopathie virale (traitement médicamenteux) < Pneumopathie virale (transmission)  Facettes :

List of bibliographic references indexed by Pneumopathie virale (traitement médicamenteux)

Number of relevant bibliographic references: 156.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000011 (2020) Matthieu Million [France] ; Jean-Christophe Lagier [France] ; Philippe Gautret [France] ; Philippe Colson [France] ; Pierre-Edouard Fournier [France] ; Sophie Amrane [France] ; Marie Hocquart [France] ; Morgane Mailhe [France] ; Vera Esteves-Vieira [France] ; Barbara Doudier [France] ; Camille Aubry [France] ; Florian Correard [France] ; Audrey Giraud-Gatineau [France] ; Yanis Roussel [France] ; Cyril Berenger [France] ; Nadim Cassir [France] ; Piseth Seng [France] ; Christine Zandotti [France] ; Catherine Dhiver [France] ; Isabelle Ravaux [France] ; Christelle Tomei [France] ; Carole Eldin [France] ; Hervé Tissot-Dupont [France] ; Stéphane Honoré [France] ; Andreas Stein [France] ; Alexis Jacquier [France] ; Jean-Claude Deharo [France] ; Eric Chabrière [France] ; Anthony Levasseur [France] ; Florence Fenollar [France] ; Jean-Marc Rolain [France] ; Yolande Obadia [France] ; Philippe Brouqui [France] ; Michel Drancourt [France] ; Bernard La Scola [France] ; Philippe Parola [France] ; Didier Raoult [France]Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France.
000012 (2020) Jan Martel [Taïwan] ; Yun-Fei Ko [Taïwan] ; John D. Young [Taïwan] ; David M. Ojcius [France]Could nasal nitric oxide help to mitigate the severity of COVID-19?
000015 (2020) Patricia Schlagenhauf [Suisse] ; Martin P. Grobusch [Pays-Bas] ; Julian D. Maier [Suisse] ; Philippe Gautret [France]Repurposing antimalarials and other drugs for COVID-19.
000016 (2020) Philippe Gautret [France] ; Jean-Christophe Lagier [France] ; Philippe Parola [France] ; Van Thuan Hoang [Viêt Nam] ; Line Meddeb [France] ; Jacques Sevestre [France] ; Morgane Mailhe [France] ; Barbara Doudier [France] ; Camille Aubry [France] ; Sophie Amrane [France] ; Piseth Seng [France] ; Marie Hocquart [France] ; Carole Eldin [France] ; Julie Finance [France] ; Vera Esteves Vieira [France] ; Hervé Tissot Tissot-Dupont [France] ; Stéphane Honoré [France] ; Andreas Stein [France] ; Matthieu Million [France] ; Philippe Colson [France] ; Bernard La Scola [France] ; Véronique Veit [France] ; Alexis Jacquier [France] ; Jean-Claude Deharo [France] ; Michel Drancourt [France] ; Pierre Edouard Fournier [France] ; Jean-Marc Rolain [France] ; Philippe Brouqui [France] ; Didier Raoult [France]Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study.
000019 (2020) Annie Ladoux [France] ; Stéphane Azoulay [France] ; Christian Dani [France][SARS-CoV-2 protease: an excellent target to develop drugs against COVID-19].
000043 (2020) Thierry Conrozier [France] ; Anne Lohse [France] ; Jean-Charles Balblanc [France] ; Pascale Dussert [France] ; Pierre-Yves Royer [France] ; Marie Bossert [France] ; Ana-Maria Bozgan [France] ; Vincent Gendrin [France] ; Aline Charpentier [France] ; Lynda Toko [France] ; Julio Badie [France] ; Chaouki Mezher [France] ; Marie-Françoise Roux [France] ; Ndri Juliette Kadiane-Oussou [France] ; Rémy Contreras [France] ; Julie Kessler [France] ; Isabelle Mazurier [France] ; Timothée Klopfenstein [France] ; Souheil Zayet [France]Biomarker variation in patients successfully treated with tocilizumab for severe coronavirus disease 2019 (COVID-19): results of a multidisciplinary collaboration.
000045 (2020) Jean-Luc Cracowski [France] ; Mathieu Molimard [France] ; Vincent Richard [France]Ultrafast response of the French Society of Pharmacology and Therapeutics to the COVID-19 pandemic.
000050 (2020) François Montastruc [France] ; Charles Romano [France] ; Jean-Louis Montastruc [France] ; Stein Silva [France] ; Thierry Seguin [France] ; Vincent Minville [France] ; Bernard Georges [France] ; Béatrice Riu-Poulenc [France] ; Olivier Fourcade [France]Pharmacological characteristics of patients infected with SARS-Cov-2 admitted to Intensive Care Unit in South of France.
000051 (2020) Jean-Christophe Lagier [France] ; Matthieu Million [France] ; Philippe Gautret [France] ; Philippe Colson [France] ; Sébastien Cortaredona [France] ; Audrey Giraud-Gatineau [France] ; Stéphane Honoré [France] ; Jean-Yves Gaubert [France] ; Pierre-Edouard Fournier [France] ; Hervé Tissot-Dupont [France] ; Eric Chabrière [France] ; Andreas Stein [France] ; Jean-Claude Deharo [France] ; Florence Fenollar [France] ; Jean-Marc Rolain [France] ; Yolande Obadia [France] ; Alexis Jacquier [France] ; Bernard La Scola [France] ; Philippe Brouqui [France] ; Michel Drancourt [France] ; Philippe Parola [France] ; Didier Raoult [France]Outcomes of 3,737 COVID-19 patients treated with hydroxychloroquine/azithromycin and other regimens in Marseille, France: A retrospective analysis.
000052 (2020) Joëlle Micallef [France] ; Thomas Soeiro [France] ; Annie-Pierre Jonville-Béra [France]Non-steroidal anti-inflammatory drugs, pharmacology, and COVID-19 infection.
000056 (2020) Joachim Alexandre [France] ; Jean-Luc Cracowski [France] ; Vincent Richard [France] ; Béatrice Bouhanick [France]Drugs acting on renin angiotensin system and use in ill patients with COVID-19.
000060 (2020) M. Roustit [France] ; R. Guilhaumou [France] ; M. Molimard [France] ; M-D Drici [France] ; S. Laporte [France] ; J-L Montastruc [France]Chloroquine and hydroxychloroquine in the management of COVID-19: Much kerfuffle but little evidence.
000061 (2020) Isabelle Lacroix [France] ; Justine Bénévent [France] ; Christine Damase-Michel [France]Chloroquine and hydroxychloroquine during pregnancy: What do we know?
000065 (2020) Alexandre Gérard [France] ; Serena Romani [France] ; Audrey Fresse [France] ; Delphine Viard [France] ; Nadège Parassol [France] ; Aurélie Granvuillemin [France] ; Laurent Chouchana [France] ; Fanny Rocher [France] ; Milou-Daniel Drici [France]"Off-label" use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers.
000071 (2020) Bernard I. Lévy [France] ; Jean-Pierre Fauvel [France]Renin-angiotensin system blockers and severe acute respiratory syndrome coronavirus 2.
000111 (2020) M. Plaze [France] ; D. Attali [France] ; A-C Petit [France] ; M. Blatzer [France] ; E. Simon-Loriere [France] ; F. Vinckier [France] ; A. Cachia [France] ; F. Chrétien [France] ; R. Gaillard [France][Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study].
000117 (2020) L. Boyer [France] ; P. Auquier [France] ; G. Fond [France][Real-life data and Covid-19: The third avenue of reseach].
000149 (2020) S. Defoort-Dhellemmes [France][Is there a need for ophthalmological surveillance in the case of short-term hydroxychloroquine treatment during this COVID-19 pandemic?]
000152 (2020) H. Javelot [France] ; P-M Llorca [France] ; D. Drapier [France] ; E. Fakra [France] ; C. Hingray [France] ; G. Meyer [France] ; S. Dizet [France] ; A. Egron [France] ; C. Straczek [France] ; M. Roser [France] ; M. Masson [France] ; R. Gaillard [France] ; P. Fossati [France] ; E. Haffen [France][Informations on psychotropics and their adaptations for patients suffering from mental disorders in France during the SARS-CoV-2 epidemic].
000191 (2020) A. Ben Dhia [France] ; S. Hamzaoui [France] ; F. Mouaffak [France][Clozapine prescription in the wake of the coronavirus (SARS CoV-2) outbreak: What measures? Why?]
000195 (2020) H. Javelot [France] ; P-M Llorca [France] ; G. Meyer [France] ; P. Fossati [France] ; E. Haffen [France][Challenges for psychotropics in the context of the SARS-Cov-2 pandemic].

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i -k "Pneumopathie virale (traitement médicamenteux)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdFr.i  \
                -Sk "Pneumopathie virale (traitement médicamenteux)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdFr.i
   |clé=    Pneumopathie virale (traitement médicamenteux)
}}
Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021